{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:41:18Z","timestamp":1790174478857,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.2515\/therapie\/2012007","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T12:22:27Z","timestamp":1334060547000},"page":"1-10","source":"Crossref","is-referenced-by-count":2,"title":["La loi de r\u00e9forme de la s\u00e9curit\u00e9 sanitaire du m\u00e9dicament et des produits de sant\u00e9 en France : effet d\u2019annonce renforcement ou bouleversement ?"],"prefix":"10.1016","volume":"67","author":[{"given":"Anne-Catherine","family":"Maillols-Perroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Tillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2012007_bb0005","unstructured":"Rapport de la mission d\u2019information de l\u2019Assembl\u00e9e nationale sur le M\u00e9diator et la pharmacovigilance du 22 juin 2011, http:\/\/www.assemblee-nationale.fr\/13\/rap-info\/i3552.asp"},{"key":"10.2515\/therapie\/2012007_bb0010","unstructured":"Rapport de l\u2019Assembl\u00e9e nationale en conclusion des travaux de la mission sur les agences sanitaires du 6 juillet 2011, http:\/\/www.assemblee-nationale.fr\/13\/rap-info\/i3627.asp"},{"key":"10.2515\/therapie\/2012007_bb0015","unstructured":"Rapport du S\u00e9nat fait au nom de la mission commune d\u2019information : \u201c M\u00e9diator : \u00e9valuation et contr\u00f4le des m\u00e9dicaments \u201c du 28 juin 2011, http:\/\/www.senat.fr\/rap\/r10-675-1\/r10-675-11.pdf"},{"key":"10.2515\/therapie\/2012007_bb0020","unstructured":"Rapport de l\u2019Igas \u00ab Enqu\u00eate sur le M\u00e9diator\u00ae \u00bb du 15 janvier 2011, http:\/\/www.igas.gouv.fr\/spip.php?article161"},{"key":"10.2515\/therapie\/2012007_bb0025","unstructured":"Rapport de l\u2019Igas sur la pharmacovigilance et la gouvernance de la cha\u00eene du m\u00e9dicament du 21 juin 2011, http:\/\/www.sante.gouv.fr\/rapport-de-l-igas-sur-la-pharmacovigilance-et-gouvernance-de-la-chaine-du-medicament.html"},{"key":"10.2515\/therapie\/2012007_bb0030","unstructured":"Rapport de synth\u00e8se des Assises du m\u00e9dicament du 23 juin 2011, http:\/\/www.sante.gouv.fr\/rapport-de-synthese-des-assises-du-medicament.html"},{"key":"10.2515\/therapie\/2012007_bb0035","unstructured":"Rapport de la mission sur la refonte du syst\u00e8me fran\u00e7ais de contr\u00f4le de l\u2019efficacit\u00e9 et de la s\u00e9curit\u00e9 des m\u00e9dicaments du Pr Debr\u00e9, D\u00e9put\u00e9 de Paris et du Pr Even, Pr\u00e9sident de l\u2019Institut Necker remis au Pr\u00e9sident de la R\u00e9publique le 16 mars 2011, http:\/\/www.sante.gouv.fr\/IMG\/pdf\/110316_Rapport_de_la_mission_sur_la_refonte_du_systeme_francais_de_controle_de_l_efficacite_et_de_la_securite_des_medicaments_de_M_le_Professeur_Bernard_Debre_depute_de_P.pdf"},{"key":"10.2515\/therapie\/2012007_bb0040","unstructured":"JORF du 30 d\u00e9cembre 2011, http:\/\/www.journal-officiel.gouv.fr\/"},{"key":"10.2515\/therapie\/2012007_bb0045","unstructured":"Loi N\u00b098-535 du 1er juillet 1998 relative au renforcement de la veille sanitaire et du contr\u00f4le de la s\u00e9curit\u00e9 sanitaire des produits destin\u00e9s \u00e0 l\u2019homme JORF du 2 juillet 1998, http:\/\/www.journal-officiel.gouv.fr\/"},{"key":"10.2515\/therapie\/2012007_bb0050","unstructured":"Directive 2010\/84\/UE du Parlement europ\u00e9en et du Conseil du 15 d\u00e9cembre 2010 modifiant, en ce qui concerne la pharmacovigilance, la directive 2001\/83\/CE instituant un code communautaire relatif aux m\u00e9dicaments \u00e0 husage humain, JOUE L 348 du 31.12.210, http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/dir_2010_84\/dir_2010_84_fr.pdf"},{"key":"10.2515\/therapie\/2012007_bb0055","unstructured":"http:\/\/www.eurostaf.fr."},{"key":"10.2515\/therapie\/2012007_bb0060","unstructured":"http:\/\/www.leem.org."},{"key":"10.2515\/therapie\/2012007_bb0065","unstructured":"Lettre de la HAS N\u00b0 29 Novembre-D\u00e9cembre 2011, http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2011-10\/lettre_has_29.pdf"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716308162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716308162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T11:36:28Z","timestamp":1554291388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716308162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0040595716308162"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2012007","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}